The Kick-off Meeting of the Agro-Food Quality Network of the Euroregion Pirynees-Mediterranean project took place on March 10th, 2021 virtually. This meeting is the launching… Read More »Kick-off Metting of the project Agri-Food Quality Network of the Euroregion
Partners/ GenoMi Diagnostics SLU GenoMI Diagnostics SLU is a start-up company established in Mallorca and dedicated to the development of in vitro diagnostic (IVD) devices,… Read More »GenoMI Diagnostics SLU
Artículo publicado en el diario ARA Balears, del día 07 de noviembre de 2020. “El Govern ignora la proposta del clúster de biotecnologia per impulsar… Read More »El Govern ignora la proposta del clúster de biotecnologia per impulsar el sector (ARA Balears)
Editorial del diario ARA Balears, del día 07 de noviembre de 2020. “La reactivació econòmica ha de passar per la innovació”
Four presentations at oral and ePoster sessions focus on the effect of SNF472 in vascular calcification disorders Palma, Spain and San Diego, USA, October 22,… Read More »Sanifit Presents New Data for SNF472 in Treatment of Vascular Calcification at ASN Kidney Week 2020
Palma, Spain and San Diego, USA, 20 August 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced the… Read More »Sanifit Appoints Adam Levy as Chief Financial Officer
The EU bank will support Palma-based Sanifit in its work to develop cutting-edge solutions in biomedical research. The venture debt operation is supported by the… Read More »Biotech innovation in Spain: the European Investment Bank provides €20 million in financing to Sanifit to develop treatments for vascular calcification
INNOVADORES, el suplemento dominical de La Razón, publica un artículo sobre Numad Medtech, empresa asociada a BIOIB. Podéis acceder al artículo completo a través del… Read More »Numad Medtech en INNOVADORES
FDA has agreed to key aspects of the clinical program, including the primary endpoint for the single pivotal phase 3 study There are approximately 175,000… Read More »Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease
Laminar seeks new sources of business financing in the stock market Given the good track record of the stock market as an alternative source of… Read More »Spanish biotechnology company Laminar Pharma joins the Growth segment of the Pre-Market Environment, in a step towards joining the stock market